Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.4B
249M shares
52-week range
$11.02 – $19.98
35% from low
Exchange
NASDAQ
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $171.9M | $194.9M | $246.2M | $270.7M | $325.1M | $401.2M | $475.7M |
| Cost of revenue | $35.8M | $37.9M | $42.6M | $50.7M | $53.2M | $62.6M | $75.2M |
| Gross profit | $136.0M | $157.0M | $203.7M | $219.9M | $271.9M | $338.6M | $400.5M |
| Gross margin | 79.2% | 80.6% | 82.7% | 81.3% | 83.6% | 84.4% | 84.2% |
| R&D | $46.6M | $54.4M | $65.5M | $80.6M | $84.4M | $98.4M | $113.9M |
| Operating income | −$1.5M | $9.2M | $13.8M | $1.0M | $33.2M | $56.9M | $66.5M |
| EBITDA | $5.6M | $17.3M | $89.5M | $130.1M | −$65.4M | −$265.3M | $103.1M |
| Net income | −$1.9M | $5.8M | $71.4M | $120.8M | −$81.1M | −$283.0M | $78.3M |
| Net margin | -1.1% | 3.0% | 29.0% | 44.6% | -24.9% | -70.5% | 16.5% |
| EPS (diluted) | -0.05 | -0.05 | 0.44 | 0.59 | -0.43 | -1.35 | 0.31 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $568M | $0.33 | $0.31–$0.34 | 5 |
| 2027 | $667M | $0.44 | $0.41–$0.47 | 5 |
| 2028 | $783M | $0.57 | $0.54–$0.60 | 2 |
| 2029 | $865M | $0.91 | $0.90–$0.93 | 1 |
Forward consensus · source: Financial Modeling Prep
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
www.cellebrite.comNo one on the platform currently holds CLBT.
No tracked institution reports a position in CLBT as of their last filing.
No one on the platform has traded CLBT yet.
| $14.8B |
| — |
| NAVNNavan, Inc. | $23.33 | +2.23% | $5.6B | — |
| QLYSQualys, Inc. | $128.44 | +4.20% | $4.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
$CLBT ok Clbt dream officially finished. Back to spac values. So sad
View on StockTwits ↗$CLBT someone knows some thing for sure. I do not think it s just that the AI fear disappeared all of a sudden……something is brewing in the background
View on StockTwits ↗$CLBT are the rumors, that Anthropic is interested in Cellebrite, really true?
View on StockTwits ↗$CLBT are we finally catching a bid!? Loving the $20 price target upgrade 👍🏼
View on StockTwits ↗Cellebrite DI shares rose sharply in midday trading after DA Davidson initiated coverage with a Buy rating and a $20 price target, boosting investor confidence in the digital forensics software company. The firm said Cellebrite’s total addressable market is large, expanding, and likely underestimated, while pointing to multiple catalysts that could support further ARR growth and market share gains. The bullish analyst call followed strong Q1 results from Cellebrite, with annual recurring revenue rising 21% year over year to $493 million and adjusted EBITDA increasing 29% to $30.6 million. The company also guided Q2 revenue to between $130 million and $133 million, implying growth of 15% to 17%. Investors largely overlooked a recent insider sale by Chief Revenue Officer Marcus Jewell, who sold 12,658 shares on May 18 at an average price of $12.77, trimming his stake by 2.8%. Instead, the market focused on improving fundamentals and the new analyst endorsement. $CLBT
View on StockTwits ↗$CLBT $AIRO $FJET $PATH $ACHR are some additional bottom plays money could rotate to. 
View on StockTwits ↗$CLBT Steadily accumulating! I believe in this management team!!!
View on StockTwits ↗https://marketbeat.com/a/8678748/ $CLBT Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at NaN× earnings vs its 18.2× historical median P/E.
Fair value ≈ $-17.54 · price $14.12 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.